Profile data is unavailable for this security.
About the company
Koninklijke Philips N.V. is the Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care & Health Informatics businesses, HealthTech Other and Legacy Items. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care & Health Informatics businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The HealthTech Other segment comprises such items, as innovation, emerging businesses, royalties, among others. The Legacy Items segment consists mainly of separation costs, legacy legal items, legacy pension costs, among others.
- Revenue in USD (TTM)20.61bn
- Net income in USD1.21bn
- Incorporated2000
- Employees77.75k
- LocationKoninklijke Philips NVHigh Tech Campus 52EINDHOVEN 5656 AGNetherlandsNLD
- Phone+31 205977777
- Fax+31 205977220
- Websitehttps://www.philips.com/
More ▼
Mergers & acquisitions
| Acquired company | PHIA:AEX since announced | Transaction value |
|---|---|---|
| Cardiologs Technologies SAS | -20.52% | -- |
| Capsule Technologies Inc | -26.66% | 635.00m |
Data delayed at least 15 minutes, as of Nov 26 2021 16:39 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cooper Companies Inc | 2.85bn | 2.92bn | 18.73bn | 12.00k | 6.48 | 2.75 | 5.81 | 6.58 | 58.64 | 58.64 | 57.24 | 137.91 | 0.3478 | 1.64 | 5.77 | 237,083.30 | 35.65 | 6.23 | 41.16 | 7.11 | 66.01 | 63.66 | 102.48 | 14.52 | 0.834 | 29.94 | 0.1927 | 0.8652 | -8.39 | 6.23 | -48.28 | 3.21 | 5.02 | 0.00 |
| Hologic, Inc. | 5.63bn | 1.87bn | 19.32bn | 6.71k | 10.66 | 4.62 | 8.48 | 3.43 | 7.21 | 7.21 | 21.75 | 16.63 | 0.699 | 4.10 | 5.71 | 840,014.90 | 23.20 | 8.33 | 27.60 | 10.17 | 67.40 | 58.35 | 33.20 | 16.16 | 2.01 | 29.01 | 0.4198 | 0.00 | 49.14 | 14.74 | 67.82 | 41.42 | 10.56 | -- |
| Insulet Corporation | 1.04bn | -29.50m | 20.37bn | 1.90k | -- | 40.89 | 526.41 | 19.64 | -0.4531 | -0.4531 | 15.46 | 7.22 | 0.5592 | 1.76 | 10.39 | 545,894.80 | -1.59 | -0.7253 | -1.78 | -0.8287 | 67.49 | 63.25 | -2.84 | -1.06 | 4.58 | 1.17 | 0.7209 | -- | 22.51 | 27.93 | -41.38 | -- | 73.44 | -- |
| Steris PLC | 3.85bn | 251.36m | 22.74bn | 13.00k | 80.75 | 3.47 | 40.03 | 5.91 | 2.82 | 2.82 | 42.41 | 65.41 | 0.4463 | 5.25 | 6.08 | 295,989.40 | 2.90 | 5.61 | 3.13 | 6.14 | 42.47 | 42.09 | 6.51 | 10.55 | 1.71 | 12.35 | 0.3447 | 37.93 | 2.53 | 6.78 | -2.52 | 29.11 | 13.61 | 16.55 |
| Zimmer Biomet Holdings Inc | 7.88bn | 849.20m | 26.24bn | 20.00k | 30.97 | 2.06 | 13.70 | 3.33 | 4.06 | 3.91 | 37.58 | 60.84 | 0.3283 | 0.9289 | 5.77 | 394,180.00 | 3.54 | 0.9027 | 3.97 | 1.01 | 70.49 | 70.93 | 10.78 | 2.99 | 0.951 | 6.25 | 0.3711 | 85.08 | -12.00 | 3.21 | -117.62 | -- | -1.16 | 1.76 |
| West Pharmaceutical Services Inc. | 2.68bn | 611.10m | 32.51bn | 9.20k | 54.53 | 14.77 | 46.20 | 12.13 | 8.05 | 8.07 | 35.29 | 29.72 | 0.9365 | 4.92 | 6.31 | 291,413.00 | 20.52 | 11.01 | 24.89 | 13.01 | 40.52 | 33.28 | 21.91 | 12.68 | 2.23 | 94.58 | 0.1034 | 18.33 | 16.69 | 8.93 | 43.24 | 29.35 | 5.79 | 7.63 |
| Koninklijke Philips NV (ADR) | 20.61bn | 1.21bn | 33.75bn | 77.75k | 28.88 | -- | 12.45 | 1.64 | 1.29 | 4.62 | 22.32 | -- | -- | -- | -- | 252,631.40 | -- | 3.98 | -- | 5.69 | 44.56 | 46.27 | 5.94 | 6.03 | -- | 63.77 | -- | 64.75 | 0.272 | 3.06 | 0.9275 | 52.53 | 2.61 | 1.63 |
| ResMed Inc. | 3.35bn | 499.75m | 36.61bn | 7.97k | 73.80 | 12.10 | 55.53 | 10.93 | 3.40 | 3.40 | 22.88 | 20.77 | 0.7163 | 2.92 | 6.23 | 420,187.70 | 10.69 | 11.98 | 12.29 | 14.03 | 57.09 | 57.66 | 14.92 | 17.49 | 1.73 | 35.71 | 0.2103 | 45.57 | 8.11 | 11.70 | -23.67 | 6.13 | 11.49 | 5.39 |
| Baxter International Inc | 12.45bn | 1.21bn | 38.20bn | 50.00k | 32.02 | 4.36 | 18.35 | 3.07 | 2.38 | 2.38 | 24.38 | 17.52 | 0.624 | 3.73 | 6.11 | 249,020.00 | 6.13 | 10.83 | 7.43 | 13.31 | 39.91 | 41.88 | 9.83 | 17.19 | 1.78 | 15.44 | 0.4032 | 20.45 | 2.74 | 3.21 | 36.56 | 22.90 | -4.89 | -5.54 |
| Align Technology, Inc. | 3.76bn | 740.05m | 50.01bn | 18.07k | 68.27 | 14.22 | 59.26 | 13.31 | 9.29 | 9.29 | 47.15 | 44.60 | 0.7463 | 5.78 | 5.07 | 207,858.60 | 14.71 | 29.32 | 20.69 | 42.44 | 74.58 | 73.28 | 19.70 | 33.47 | 1.26 | -- | 0.00 | 0.00 | 2.71 | 23.93 | 301.08 | 65.27 | 23.72 | -- |
Data as of Nov 26 2021. Currency figures normalised to Koninklijke Philips NV's reporting currency: US Dollar USD
5.72%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| T. Rowe Price Associates, Inc. (Investment Management)as of 30 Sep 2021 | 19.14m | 2.09% |
| Fiduciary Management, Inc.as of 30 Sep 2021 | 7.60m | 0.83% |
| Wellington Management Co. LLPas of 23 Nov 2021 | 6.48m | 0.71% |
| Managed Account Advisors LLCas of 30 Sep 2021 | 5.13m | 0.56% |
| BlackRock Investment Management LLCas of 30 Sep 2021 | 3.21m | 0.35% |
| AllianceBernstein LPas of 30 Sep 2021 | 2.75m | 0.30% |
| Strategic Advisers LLCas of 30 Sep 2021 | 2.48m | 0.27% |
| American Century Investment Management, Inc.as of 30 Sep 2021 | 2.40m | 0.26% |
| Capital Research & Management Co. (International Investors)as of 30 Sep 2021 | 1.95m | 0.21% |
| Fidelity Management & Research Co. LLCas of 30 Sep 2021 | 1.33m | 0.15% |
More ▼
Data from 30 Sep 2021 - 30 Sep 2021Source: FactSet Research Systems Inc.
